<DOC>
	<DOC>NCT02159001</DOC>
	<brief_summary>Electroconvulsive therapy (ECT) is one of the oldest neuromodulation treatments still used in psychiatry. Only case reports and open label non-randomized studies have been published of ECT in clozapine-resistant schizophrenia patients. The purpose of this trial is to study the efficacy and cognitive effects of add-on ECT treatment (10-course) in schizophrenia patients taking clozapine.</brief_summary>
	<brief_title>Electroconvulsive Therapy in Clozapine-resistant Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>diagnosis of schizophrenia or schizoaffective disorder treatmentresistant to clozapine age 18 64 years capacity and willingness to give informed consent serious somatic illness progressive neurological illness, recent brain damage or sequela of serious brain damage ECT less than 3 months prior to this trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>clozapine</keyword>
	<keyword>ECT</keyword>
	<keyword>PANSS</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>treatment</keyword>
</DOC>